Drugs / Fluticasone/Salmeterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00404261 Background | Jan → Aug 2007 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone/Salmeterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00404261 ↗ |
| Route | Inhaled | “Metered Dose Inhaler (MDI)” NCT00404261 ↗ |